GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
12.29
+0.19 (1.53%)
Aug 8, 2025, 12:44 PM - Market open
Ligand Pharmaceuticals Employees
GH Research had 50 employees as of December 31, 2024. The number of employees increased by 1 or 2.04% compared to the previous year.
Employees
50
Change (1Y)
1
Growth (1Y)
2.04%
Revenue / Employee
n/a
Profits / Employee
-$820,340
Market Cap
762.02M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 50 | 1 | 2.04% |
| Dec 31, 2023 | 49 | 17 | 53.13% |
| Dec 31, 2022 | 32 | 18 | 128.57% |
| Dec 31, 2021 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GHRS News
- 1 day ago - GH Research Reports Second Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 16 days ago - GH Research Announces Global Pivotal Program Plans and Further Development Updates - GlobeNewsWire
- 7 weeks ago - GH Research Submits Complete IND Hold Response to FDA Ahead of Schedule - GlobeNewsWire
- 3 months ago - GH Research Announces Acceptance of Pharmaceutical Pipeline Presentation and Late-Breaking Posters at the American Society of Clinical Psychopharmacology 2025 Annual Meeting - GlobeNewsWire
- 3 months ago - GH Research Reports First Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 5 months ago - GH Research Reports Full Year 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 6 months ago - GH Research Announces Pricing of $150 Million Public Offering - GlobeNewsWire
- 6 months ago - GH Research Announces Proposed Public Offering - GlobeNewsWire